Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Chartash

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Arthritis and Rheumatism|November 1, 1988
Tendon rupture in systemic lupus erythematosusR A Furie, E K Chartash
The Journal of Clinical Investigation|November 1, 1989
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cellsE K Chartash, M K Crow, S M Friedman
Seminars in Arthritis and Rheumatism|August 1, 1992
Septic subdeltoid bursitisE K Chartash, P K Good, E S Gould, et al.
The Journal of Experimental Medicine|November 1, 1986
Antigen-specific, MHC nonrestricted T helper cell-induced B cell activationS M Friedman, J A Jover, E K Chartash, et al.
American Heart Journal|November 1, 1992
Cardiac manifestations of the antiphospholipid syndromeS D Kaplan, E K Chartash, R A Pizzarello, et al.
Clinical Immunology and Immunopathology|October 1, 1989
T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cellsJ A Jover, E K Chartash, B Kushner, et al.
The American Journal of Medicine|April 1, 1989
Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndromeE K Chartash, D M Lans, S A Paget, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Direct human T helper cell-induced B cell activation is not mediated by inositol lipid hydrolysisE K Chartash, A Imai, M C Gershengorn, et al.
The Journal of Clinical Investigation|June 1, 1989
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretionJ Laurence, S M Friedman, E K Chartash, et al.
Clinical and Experimental Rheumatology|January 5, 2008
Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritisS Yount, M V Sorensen, D Cella, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Arthritis and Rheumatism|November 1, 1988
Tendon rupture in systemic lupus erythematosusR A Furie, E K Chartash
The Journal of Clinical Investigation|November 1, 1989
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cellsE K Chartash, M K Crow, S M Friedman
Seminars in Arthritis and Rheumatism|August 1, 1992
Septic subdeltoid bursitisE K Chartash, P K Good, E S Gould, et al.
The Journal of Experimental Medicine|November 1, 1986
Antigen-specific, MHC nonrestricted T helper cell-induced B cell activationS M Friedman, J A Jover, E K Chartash, et al.
American Heart Journal|November 1, 1992
Cardiac manifestations of the antiphospholipid syndromeS D Kaplan, E K Chartash, R A Pizzarello, et al.
Clinical Immunology and Immunopathology|October 1, 1989
T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cellsJ A Jover, E K Chartash, B Kushner, et al.
The American Journal of Medicine|April 1, 1989
Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndromeE K Chartash, D M Lans, S A Paget, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Direct human T helper cell-induced B cell activation is not mediated by inositol lipid hydrolysisE K Chartash, A Imai, M C Gershengorn, et al.
The Journal of Clinical Investigation|June 1, 1989
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretionJ Laurence, S M Friedman, E K Chartash, et al.
Clinical and Experimental Rheumatology|January 5, 2008
Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritisS Yount, M V Sorensen, D Cella, et al.
Pageof 2